KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Charles River Laboratories International (CRL) Shares Repurchased (2016 - 2025)

Charles River Laboratories International has reported Shares Repurchased over the past 17 years, most recently at $96000.0 for Q4 2025.

  • Quarterly results put Shares Repurchased at $96000.0 for Q4 2025, down 22.58% from a year ago — trailing twelve months through Dec 2025 was $360.7 million (up 202.64% YoY), and the annual figure for FY2025 was $360.7 million, up 202.64%.
  • Shares Repurchased for Q4 2025 was $96000.0 at Charles River Laboratories International, up from $93000.0 in the prior quarter.
  • Over the last five years, Shares Repurchased for CRL hit a ceiling of $353.1 million in Q1 2025 and a floor of $24000.0 in Q3 2022.
  • Median Shares Repurchased over the past 5 years was $4.4 million (2021), compared with a mean of $29.2 million.
  • Biggest five-year swings in Shares Repurchased: surged 265126.32% in 2024 and later tumbled 99.91% in 2025.
  • Charles River Laboratories International's Shares Repurchased stood at $267000.0 in 2021, then crashed by 40.45% to $159000.0 in 2022, then decreased by 12.58% to $139000.0 in 2023, then fell by 10.79% to $124000.0 in 2024, then fell by 22.58% to $96000.0 in 2025.
  • The last three reported values for Shares Repurchased were $96000.0 (Q4 2025), $93000.0 (Q3 2025), and $7.4 million (Q2 2025) per Business Quant data.